Allarity Therapeutics Statistics
Total Valuation
ALLR has a market cap or net worth of $15.66 million. The enterprise value is $20.96 million.
| Market Cap | 15.66M |
| Enterprise Value | 20.96M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026, before market open.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ALLR has 15.91 million shares outstanding. The number of shares has increased by 92.11% in one year.
| Current Share Class | 15.91M |
| Shares Outstanding | 15.91M |
| Shares Change (YoY) | +92.11% |
| Shares Change (QoQ) | -0.36% |
| Owned by Insiders (%) | 0.31% |
| Owned by Institutions (%) | 8.05% |
| Float | 15.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 45.38 |
| Forward PS | n/a |
| PB Ratio | 4.43 |
| P/TBV Ratio | 4.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 60.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.11, with a Debt / Equity ratio of 6.30.
| Current Ratio | 1.11 |
| Quick Ratio | 0.64 |
| Debt / Equity | 6.30 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.15 |
Financial Efficiency
Return on equity (ROE) is -157.09% and return on invested capital (ROIC) is -34.28%.
| Return on Equity (ROE) | -157.09% |
| Return on Assets (ROA) | -25.31% |
| Return on Invested Capital (ROIC) | -34.28% |
| Return on Capital Employed (ROCE) | -305.29% |
| Weighted Average Cost of Capital (WACC) | 5.27% |
| Revenue Per Employee | $43,125 |
| Profits Per Employee | -$1.54M |
| Employee Count | 8 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.36% in the last 52 weeks. The beta is 0.57, so ALLR's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | -40.36% |
| 50-Day Moving Average | 1.25 |
| 200-Day Moving Average | 1.24 |
| Relative Strength Index (RSI) | 34.19 |
| Average Volume (20 Days) | 116,116 |
Short Selling Information
The latest short interest is 111,895, so 0.70% of the outstanding shares have been sold short.
| Short Interest | 111,895 |
| Short Previous Month | 119,843 |
| Short % of Shares Out | 0.70% |
| Short % of Float | 0.71% |
| Short Ratio (days to cover) | 1.18 |
Income Statement
In the last 12 months, ALLR had revenue of $345,000 and -$12.33 million in losses. Loss per share was -$0.79.
| Revenue | 345,000 |
| Gross Profit | 345,000 |
| Operating Income | -10.80M |
| Pretax Income | -12.33M |
| Net Income | -12.33M |
| EBITDA | -10.80M |
| EBIT | -10.80M |
| Loss Per Share | -$0.79 |
Balance Sheet
The company has $16.98 million in cash and $22.29 million in debt, with a net cash position of -$5.30 million or -$0.33 per share.
| Cash & Cash Equivalents | 16.98M |
| Total Debt | 22.29M |
| Net Cash | -5.30M |
| Net Cash Per Share | -$0.33 |
| Equity (Book Value) | 3.54M |
| Book Value Per Share | 0.22 |
| Working Capital | 3.15M |
Cash Flow
In the last 12 months, operating cash flow was -$13.71 million and capital expenditures -$72,000, giving a free cash flow of -$13.78 million.
| Operating Cash Flow | -13.71M |
| Capital Expenditures | -72,000 |
| Depreciation & Amortization | -6,000 |
| Net Borrowing | 20.00M |
| Free Cash Flow | -13.78M |
| FCF Per Share | -$0.87 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -3,128.99% |
| Pretax Margin | -3,575.07% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ALLR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -92.11% |
| Shareholder Yield | -92.11% |
| Earnings Yield | -78.78% |
| FCF Yield | -88.03% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 11, 2024. It was a reverse split with a ratio of 1:30.
| Last Split Date | Sep 11, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
ALLR has an Altman Z-Score of -6.52. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.52 |
| Piotroski F-Score | n/a |